Search results
Atara (ATRA) Up 11% on Regulatory Update From Blood Cancer Study
Zacks via Yahoo Finance· 7 months agoAtara (ATRA) rises 11% on an update regarding the regulatory pathway for the company's lead product...
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
InvestorPlace via Yahoo Finance· 1 year agoIn general, biotech stocks are not ideal for conservative investors. The companies in search of the...
Why Atara Biotherapeutics Stock Is Crashing Today
Motley Fool· 2 years agoShares of the next-generation cell therapy company Atara Biotherapeutics (NASDAQ: ATRA) are getting hammered today. Prior to Wednesday's opening bell,...
3 Doomed Biotech Stocks Destined for Disaster
InvestorPlace via Yahoo Finance· 9 months agoThe world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to...
Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe
Zacks via Yahoo Finance· 2 years agoSeagen (SGEN) focuses on improving sales of its marketed drugs approved for different types of...
10 Stocks That Will Go Up 1000 Percent
Insider Monkey via Yahoo Finance· 9 months agoIn this article, we will take a look at the 10 stocks that will go up 1000 percent. To see more such companies, go directly to 5 Stocks That Will Go Up...
Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study
Zacks via Yahoo Finance· 1 year agoData from a late-stage study shows that treatment with Karuna's (KRTX) lead candidate, KarXT, led to...
